PEVArx

by Innovus Pharmaceuticals · capsule · 60 capsules

  • On the market (NIH)
  • UPC 3 57483 00026 4
  • DSLD label 181987
  • Serving 1 to 2 capsules; amounts per 2 capsules
  • 30 servings

PEVArx by Innovus Pharmaceuticals lists 7 ingredients, 7 with an amount per serving of 2 capsules, such as 800 mcg of vitamin B6, 8 mg of magnesium, 400 mg of L-tyrosine and 400 mg of DL-phenylalanine. Its current label entered the NIH Dietary Supplement Label Database on October 25, 2018.

What is in PEVArx?

Each row as the label prints it, per serving of 2 capsules. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

PEVArx: Supplement Facts rows against the market (DSLD label 181987, January 2026 release)
IngredientAmount% DVAmong products listing it
Vitamin B6as Pyridoxine HydrochlorideVitamin B6 (Form: from Pyridoxine HCl)800 mcg47%Vitamin B6 in PEVArx against 15,277 products0.8 mg per serving; the middle half of products list 2 mg to 20 mg, the median 6 mg.DV 1.7 mgUL 100 mg0.8 mg

93% of 15,277 products listing vitamin B6 give more (median 6 mg).

Magnesiumas Magnesium OxideMagnesium (Form: from Magnesium Oxide)8 mg1%Magnesium in PEVArx against 14,003 products8 mg per serving; the middle half of products list 30 mg to 200 mg, the median 86 mg.UL 350 mgDV 420 mg8 mg

94% of 14,003 products listing magnesium give more (median 86 mg).

L-Tyrosine400 mgTyrosine in PEVArx against 1,680 products400 mg per serving; the middle half of products list 150 mg to 989 mg, the median 500 mg.400 mg

56% of 1,680 products listing tyrosine give more (median 500 mg).

DL-Phenylalanine400 mgDL-phenylalanine in PEVArx against 155 products400 mg per serving; the middle half of products list 135 mg to 500 mg, the median 300 mg.400 mg

Higher than 64% of 155 products listing DL-phenylalanine (median 300 mg).

L-Tryptophan100 mgTryptophan in PEVArx against 605 products100 mg per serving; the middle half of products list 55 mg to 471 mg, the median 123 mg.100 mg

53% of 605 products listing tryptophan give more (median 123 mg).

L-Glutamine52 mgGlutamine in PEVArx against 1,850 products0.052 g per serving; the middle half of products list 0.356 g to 3 g, the median 1 g.0.052 g

93% of 1,850 products listing glutamine give more (median 1 g).

AstraGin20 mg
BioPerine20 mgBlack Pepper in PEVArx against 2,363 products20 mg per serving; the middle half of products list 5 mg to 10 mg, the median 5 mg.20 mg

Higher than 95% of 2,363 products listing black pepper (median 5 mg).

Source: NIH ODS Dietary Supplement Label Database, label 181987 (entered October 25, 2018), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

The rows in the top or bottom tenth of the products that list the same ingredient, and any above the adult upper limit at the most servings a day the directions give:

  • 93% of the 15,277 products that print an amount of vitamin B6 list more than its 0.8 mg of vitamin B6 (median 6 mg).
  • 94% of the 14,003 products that print an amount of magnesium list more than its 8 mg of magnesium (median 86 mg).
  • 93% of the 1,850 products that print an amount of glutamine list more than its 0.052 g of L-glutamine (filed by NIH under glutamine) (median 1 g).
  • Its 20 mg of BioPerine (filed by NIH under black pepper) is higher than 95% of the 2,363 black pepper products that print an amount; 81 list more.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

The products whose ingredient lists overlap most with PEVArx's, rare ingredients counting for more.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested Use: Ask your doctor before taking PEVArx. As a dietary supplement, take one (1) capsule daily with a meal and if well tolerated increase to two (2) capsules per day or as directed by your healthcare practitioner.
Warnings
Warnings: Not for use in persons under the age of 18.
Ask your doctor before using PEVArx.
Do not use if allergic to any ingredient in PEVArx.
Stop using if you experience any side effect.
Do not use if inner seal or outer neck band is broken.
Keep out of the reach of children.
Storage
Caution: Keep tightly closed in a cool dry place at controlled room temperature of 15(0)-30(0)C (59(0)-86(0)F).

Source: label statements in DSLD label 181987.

What else is on the label?

Other ingredients: Hydroxypropyl Methylcellulose, Rice concentrate, Silica.

How many labels does PEVArx have?

One label is on file, entered on October 25, 2018.

  1. Label 181987 (current) Entered October 25, 2018 · on the market · 60 capsules · UPC 3 57483 00026 4

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Innovus Pharmaceuticals, Inc. (distributor), San Diego, CA. All Innovus Pharmaceuticals products.

Where next?